Plasma concentration of asymmetrical dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

被引：0
|
作者：
Lajer, M.
Tarnow, L.
Jorsal, A.
Teerlink, T.
Parving, H.-H.
Rossing, P.
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Univ Copenhagen Hosp, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[4] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1138
引用
下载
收藏
页码：S468 / S468
页数：1
相关论文
共 50 条
  • [1] Plasma concentration of asymmetric climethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
    Lajer, Maria
    Tarnow, Lise
    Jorsal, Anders
    Teerlink, Tom
    Parving, Hans-Henrik
    Rossing, Peter
    DIABETES CARE, 2008, 31 (04) : 747 - 752
  • [2] Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
    Astrup, AS
    Tarnow, U
    Rossing, P
    Hansen, BV
    Hilsted, J
    Parving, HH
    DIABETES CARE, 2006, 29 (02) : 334 - 339
  • [3] Elevated placental growth factor (PIGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy
    Tarnow, L
    Astrup, AS
    Parving, HH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2005, 65 : 73 - 79
  • [4] Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy
    Tarnow, L
    Fagerudd, JA
    Rossing, P
    Poirier, O
    Nielsen, FS
    Parving, HH
    DIABETES CARE, 2000, 23 (01) : 30 - 33
  • [5] Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes
    Tarnow, L
    Hovind, P
    Teerlink, T
    Stehouwer, CDA
    Parving, HH
    DIABETES CARE, 2004, 27 (03) : 765 - 769
  • [6] Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in Type 1 diabetes.
    Tarnow, L
    Hovind, P
    Teerlink, T
    Stehouwer, CDA
    Parving, HH
    DIABETOLOGIA, 2003, 46 : A329 - A329
  • [7] Plasma α-defensin is associated with diabetic nephropathy and mortality in type 1 diabetic patients
    Joseph, G.
    Tarnow, L.
    Hansen, T. K.
    Parving, H-H.
    Flyvbjerg, A.
    Frystyk, J.
    DIABETOLOGIA, 2006, 49 : 7 - 8
  • [8] Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
    Nijveldt, RJ
    Teerlink, T
    Van der Hoven, B
    Siroen, MPC
    Kuik, DJ
    Rauwerda, JA
    Van Leeuwen, PAM
    CLINICAL NUTRITION, 2003, 22 (01) : 23 - 30
  • [9] Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
    RJ Nijveldt
    T Teerlink
    B van der Hoven
    MPC Siroen
    DJ Kuik
    JA Rauwerda
    PAM van Leeuwen
    Critical Care, 7 (Suppl 2):
  • [10] Cardiovascular morbidity and early mortality clusters in parents of IDDM patients with diabetic nephropathy
    Tarnow, L
    Fagerud, J
    Rossing, P
    Nielsen, FS
    Cambien, F
    Parving, HH
    DIABETOLOGIA, 1998, 41 : A291 - A291
12345